Because it is a relatively new program, DSCB cannot yet boast about its alumni. However, students who graduate with a doctoral degree from the DSCB program will be well positioned to capitalize on the high levels of enthusiasm for such training by recruiters from academia and the private sector, especially in the biotechnology and pharmaceutical industries. Moreover, because of their direct impact on human health, the fields of developmental and stem cell biology are commanding significant resources from state and federal funding agencies such as the California Institute for Regenerative Medicine (CIRM) and National Institutes of Health.
Detailed information about career outcomes for this program will be posted here after the first cohort graduates, when career outcomes data on this cohort are available. The DSCB program enrolled its first cohort in 2011.
Go back to the Developmental and Stem Cell Biology program.